Article
Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis.
Journal of the Chinese Medical Association : JCMA - 1 Feb 2023
Chang Hao-Yun, Liu Chao-Yu, Lo Yen-Li, Chiou Shih-Hwa, Lu Kai-Hsi, Lee Ming-Cheng, Wang Yuan-Hung
Abstract excerpt
BACKGROUND: Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is an immune checkpoint and regulates the immune function of T cells. However, previous findings regarding the association of CTLA-4 polymorphisms and breast cancer remain inconclusive. Therefore, we performed a meta-analysis to investigate the potential effects of five polymorphisms (-1722 T/C, -1661 A/G -318 C/T, +49 A/G, and CT60 A/G) in the CTLA-4 gene on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
